Interpace, Affirma, and Thyroseq Performance Characteristics in 341 Bethesda Category III/IV Thyroid Nodules

被引:0
|
作者
Connelly, C. F. [1 ]
Cimic, A. [2 ]
Baskota, S. [2 ]
机构
[1] Columbia Univ, Irving Med Ctr, New York Presbyterian, New York, NY USA
[2] Columbia Univ, Irving Med Ctr, New York, NY USA
关键词
D O I
10.1093/ajcp/aqad150.051
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
aqad150.05
引用
收藏
页码:S23 / S24
页数:2
相关论文
共 50 条
  • [21] Value of Thyroid Imaging Reporting and Data System in Initial Bethesda Category III Thyroid Nodules
    Yan, Caoxin
    Luo, Zhiyan
    Lin, Zimei
    Xu, Shouxing
    Luo, Yunkai
    Chen, Jian
    SCIENTIFIC PROGRAMMING, 2021, 2021
  • [22] Ultrasound characteristics of thyroid nodules facilitate interpretation of the malignant risk of Bethesda system III/IV thyroid nodules and inform therapeutic schedule
    Li, Fu
    Pan, Denghua
    Wu, Yuquan
    Peng, Jinbo
    Li, Qing
    Gui, Xiaolong
    Ma, Wei
    Yang, Hong
    He, Yun
    Chen, Junqiang
    DIAGNOSTIC CYTOPATHOLOGY, 2019, 47 (09) : 881 - 889
  • [23] Impact of ultrasound elastography in evaluating Bethesda category IV thyroid nodules with histopathological correlation
    Latia, Monica
    Borlea, Andreea
    Mihuta, Monica Simina
    Neagoe, Octavian Constantin
    Stoian, Dana
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [24] ThyroSeq v3 for Bethesda III and IV: An institutional experience
    Desai, Dimpi
    Lepe, Marcos
    Baloch, Zubair Wahld
    Mandel, Susan J.
    CANCER CYTOPATHOLOGY, 2021, 129 (02) : 164 - 170
  • [25] Malignancy in Thyroid Nodules with Bethesda III Category on Repeat Fine Needle Aspiration Biopsy
    Ng, Jennifer Lourdes
    Escueta, Luz Margaret
    Dampil, Oliver Allan
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2023, 38 (02): : 86 - 93
  • [26] Risk Stratification of Thyroid Nodules Diagnosed as Bethesda Category III by Ultrasound, Size, and Cytology
    Ahn, Hye Shin
    Na, Dong Gyu
    Kim, Ji-Hoon
    KOREAN JOURNAL OF RADIOLOGY, 2024, 25 (10) : 924 - 933
  • [27] Risk Stratification of Thyroid Nodules with Bethesda III Category: The Experience of a Territorial Healthcare Hospital
    Al Dawish, Mohamed
    Robert, Asirvatham Alwin
    Al Shehri, Khalid
    Hawsawi, Salwa
    Mujammami, Muhammad
    Al Basha, Ibrahim Ali
    Alrasheed, Mohannad
    Asiri, Shuaa
    Alzouman, Muneerah
    Alkharashi, Eyad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)
  • [28] Evidence for overestimation of the prevalence of malignancy in indeterminate thyroid nodules classified as Bethesda category III
    Iskandar, Mazen E.
    Bonomo, Giovanni
    Avadhani, Vaidehi
    Persky, Mark
    Lucido, David
    Wang, Beverly
    Marti, Jennifer L.
    SURGERY, 2015, 157 (03) : 510 - 517
  • [29] Prediction of Malignancy in Bethesda Category III Nodules: Application of Thyroid Imaging Reporting System
    Senol, Kazim
    Katar, Kagan
    Yuksel, Cemil
    Saylam, Baris
    Tez, Mesut
    AMERICAN SURGEON, 2015, 81 (11) : E351 - E352
  • [30] Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management
    Chan, Wen-Hui
    Chiang, Pi-Ling
    Lin, An-Ni
    Chang, Yen-Hsiang
    Lin, Wei-Che
    ULTRASONOGRAPHY, 2024, 43 (06) : 395 - 406